James V. Caruso, CEO of Cellectar Biosciences ($CLRB), made one open market purchase of shares worth $49,900 in the last year, with the latest on July 2, 2025. He ranks 3,036th among nearly 5,000 insiders for purchase volume, below the average of $1.5 million across 3.3 transactions. Caruso reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 2, 2025 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | Chief Executive Officer | P | Common Stock | 10000 | $4.99 | 11,638.0000 | 1,608,799 | 610.50% | 0.62% |
| July 2, 2025 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | Chief Executive Officer | P | Warrants | 10000 | $0.01 | 10,000.0000 | 1,608,799 | 9999.99% | 0.62% |
| Feb. 14, 2025 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 900000 | $0.00 | 900,000.0000 | 1,238,125 | 9999.99% | 72.69% |
| June 14, 2024 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 900000 | $0.00 | 900,000.0000 | 29,346,679 | 9999.99% | 3.07% |
| Dec. 8, 2023 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | President and CEO | A | Common Stock | 40596 | $0.00 | 49,236.0000 | 11,308,738 | 469.86% | 0.36% |
| June 23, 2023 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 261000 | $0.00 | 261,000.0000 | 11,261,217 | 9999.99% | 2.32% |
| Jan. 17, 2023 | Cellectar Biosciences, Inc. | $CLRB | CARUSO JAMES V | President and CEO | A | Stock option (right to buy) | 261000 | $0.00 | 261,000.0000 | 7,055,665 | 9999.99% | 3.70% |